Signaling Pathway Activation After Exercise in Patients With Chronic Obstructive Pulmonary Disease (SIM)

This study has been completed.
Sponsor:
Collaborator:
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Bruno Lemire, Laval University
ClinicalTrials.gov Identifier:
NCT01561625
First received: March 20, 2012
Last updated: May 3, 2013
Last verified: May 2013
  Purpose

Muscle weakness and atrophy are important consequences of chronic obstructive pulmonary disease (COPD). Although resistance exercises increase strength and muscle mass in patients with COPD, the response to training appears to be suboptimal in these individuals. A dysregulation in the signaling pathways involved in the regulation of muscle mass could play an important role in this phenomenon.

Hypothesis: Proteins involved in muscle mass regulation will be less activated in the quadriceps of patients with COPD following the acute bout of resistance training exercise compared to healthy age-matched controls.


Condition Intervention
Chronic Obstructive Pulmonary Disease
Other: exercise

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Official Title: Signaling Pathway Activation in the Quadriceps of Patients With COPD After an Acute Bout of Resistance

Resource links provided by NLM:


Further study details as provided by Laval University:

Primary Outcome Measures:
  • Post-exercise signaling proteins phosphorylation level in the quadriceps of COPD patients and age-matched healthy controls [ Time Frame: 2 hours post-exercise ] [ Designated as safety issue: No ]
    Phosphorylation status of key proteins (Akt, p70, mTOR, p38, JNK, ERK) will be lesser modulated in the quadriceps of patients with COPD compare to healthy controls. The phosphorylated as well as the total protein levels will be measured by western blot. The data will be presented as arbitrary units and compared with values obtained in healthy age-matched healthy controls.


Enrollment: 21
Study Start Date: October 2009
Study Completion Date: April 2013
Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: exercise
    resistance training exercise, 1 session, 3 exercises, 80% of max
Detailed Description:

Our objective is to investigate the impact of an acute bout of resistance training on key signaling pathways involved in the regulation of muscle mass in moderate to severe COPD (FEV1 under 60% of predicted). Key proteins of signaling intramuscular pathways involved in protein synthesis and degradation will be measured before after 72 contractions of the quadriceps. The exercise protocol was designed to match the actual exercise prescription model use in the context of pulmonary rehabilitation. A squat, leg press and leg extension will be done at 80% of max with one minute rest between sets. A biopsy of the quadriceps will be done before and after exercise in order to measure phosphorylated kinases, total protein content and mRNA expressions. All our patients will undergo a thorough baseline assessment in pulmonary capacity, muscle force and body composition.

  Eligibility

Ages Eligible for Study:   50 Years to 75 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male
  • COPD with an FEV1 of under 60% of predicted
  • non-smoker
  • Between 50 and 75 years old

Exclusion Criteria:

  • All inflammatory disease (HIV, Cancer, renal and cardiac deficiency)
  • Hormonal dysregulation
  • Inferior limb pathology
  • Neuromuscular pathology
  • History of tabacco or alcool abuse
  • Oxygen dependent
  • Recent exacerbation (2 months) of the symptoms of COPD
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01561625

Locations
Canada, Quebec
IUCPQ
Quebec City, Quebec, Canada, G1V 4G5
Sponsors and Collaborators
Laval University
Canadian Institutes of Health Research (CIHR)
Investigators
Principal Investigator: François Maltais, MD Laval University
  More Information

No publications provided

Responsible Party: Bruno Lemire, Étudiant au doctorat, Laval University
ClinicalTrials.gov Identifier: NCT01561625     History of Changes
Other Study ID Numbers: SIM-COPD-20458
Study First Received: March 20, 2012
Last Updated: May 3, 2013
Health Authority: Canada: Ethics Review Committee

Keywords provided by Laval University:
COPD
exercise training

Additional relevant MeSH terms:
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on September 22, 2014